switching from semaglutide to tirzepatide reviews vs Semaglutide: What's the Difference? Switching between Semaglutide and Tirzepatide?

The review focuses explicitly on Glucagon-Like Peptide-1 (GLP-1) receptor agonists, newer multi-receptor agonists, and emerging oral small-molecule therapies

For routine antioxidant or longevity support, bypassing digestion does not automatically justify bypassing caution

GLP-1 therapy has also shown benefit in improving atherothrombosis markers (e.g., inflammation, endothelial dysfunction, clotting in this population)

If you were to take a Tyrosine supplement whilst also taking an MAOI you could dangerously increase your blood pressure and end up in hypertensive crisis

As these shortages resolve, it is unclear how quickly inappropriate or illegal distribution of copy-cat GLP-1 RAs will cease